An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.
H
HSG
Activity from announced rounds
Activity in this selectionOct 6, 2026 · AI · Jan 1, 2026
HSG is the investment firm formerly known as Sequoia China, as identified in Clipto’s financing release. Full-Life also names it in its own announcement.
Recorded funding activity
The recorded activity includes Anew’s AI drug discovery, Clipto’s video-library tools and Math Magic’s generation of 3D models and physical products. Named HSG funds retain their separate identities.
Sources
- Rounds participated in
- 5
- Confirmed lead rounds
- 1 3 roles undisclosed
- New companies
- 5 First participation on record · 0 follow-on
- Funding in participating rounds
- $535M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
5 in this selectionAnew Labs
$290MFunding
LeadClipto
Clipto builds AI tools for searching and working with video and audio libraries.
$15MFunding
ParticipantMath Magic
AI platform generating 3D models and personalized physical products
UndisclosedSeries A+
Role not disclosedROBOTERA
Builds humanoid robots with fully in-house hardware for logistics and industrial deployment at scale
$200MGrowth
Role not disclosedDify
Helps teams build deploy and operate production-grade AI applications and agentic workflows
$30MPre-Series A
Role not disclosed